| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10911003 | Lung Cancer | 2014 | 5 Pages | 
Abstract
												ALK positive lung adenocarcinomas are more likely than EGFR mutant lung adenocarcinomas to be associated with larger volume, multifocal thoracic lymphadenopathy. While routine testing for ALK should be standard, the presence of such characteristics in a solid tumor should further prompt testing for ALK rearrangement.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cancer Research
												
											Authors
												Darragh F. Halpenny, Gregory J. Riely, Sara Hayes, Helena Yu, Junting Zheng, Chaya S. Moskowitz, Michelle S. Ginsberg, 
											